Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.24.1.1.u2
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

The following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

 

   

March 31, 2024

(Unaudited)  

   

March 31, 2023

(Unaudited)  

 
Options to purchase common stock     126,265       115,598  
Warrants to purchase common stock     304,962       304,962  
Total anti-dilutive securities     431,227       420,560